Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

LncRNA SLNCR phenocopies the E2F1 DNA binding site to promote melanoma progression

Cell Reports(2025)10.1016/j.celrep.2025.115608Source: DataRank Database

LncRNA SLNCR phenocopies the E2F1 DNA binding site to promote melanoma progression is a research paper published in Cell Reports (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

geo pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: goldTopics (55)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Eleni Anastasakou ORCID,Leinal Sejour,Yufei Wang ORCID,León Wert-Lamas,Christopher Rauchet

Live enrichment

PubMed:40279246 PMC:PMC12172627

National Center for Advancing Translational Sciences

Grant: R01HL145714

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Grant: P2EZP3_184225

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Grant: P400PB_194396

National Cancer Institute Division of Cancer Epidemiology and Genetics

Grant: R01CA258776

National Institute of Environmental Health Sciences

Grant: ZIA ES43010

National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases

Grant: DP1DK126161

Swiss National Science Foundation

Grant: 184225

Epigenetic Reprogramming of Macrophage Polarization

Intramural NIH HHS

Grant: ZIA ES043010

Swiss National Science Foundation

Grant: 194396

Engineering a DNA-inducible CRISPR platform for high precision editing

National Cancer Institute

National Institutes of Health

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.celrep.2025.115608

publisherhttps://api.elsevier.com/content/article/PII:S2211124725003791?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124725003791?httpAccept=text/plain

repositoryhttps://doaj.org/article/9642dfda07b5400ba9ebdfb97d2b99b6

https://www.ncbi.nlm.nih.gov/pmc/articles/12172627

Fields of Study

0301 basic medicine03 medical and health sciencesE2F1 Transcription FactorRNA, Long NoncodingBinding SitesAnimalsMelanomaHumansMiceMolecular Dynamics SimulationCell Line, TumorDisease ProgressionCell ProliferationCell MovementProtein BindingDNA

MeSH Terms

Cell Line, TumorAnimalsHumansMiceMelanomaDisease ProgressionDNACell ProliferationCell MovementBinding SitesProtein BindingE2F1 Transcription FactorMolecular Dynamics SimulationRNA, Long Noncoding

Keywords

MelanomaE2F1Molecular Dynamics SimulationsLong Non-coding RnaRna-emsaCp: CancerCp: GenomicsSlncrTranscription Factor-rna BindingBinding SitesQH301-705.5DNAMolecular Dynamics SimulationArticleMiceCell MovementCell Line, TumorDisease ProgressionAnimalsHumansRNA, Long NoncodingBiology (General)E2F1 Transcription FactorCell ProliferationProtein Binding